Pathology - grading and staging of GEP-NETs

Area of Science:

• Oncology
• Gastroenterology
• Pathology

Background:

• Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are a heterogeneous group of neoplasms with rising incidence and prevalence.
• GEP-NETs are among the most common gastrointestinal tumours, often presenting as metastatic or unresectable disease.
• Accurate diagnosis and prognostic stratification are crucial for effective management of GEP-NETs.

Purpose of the Study:

• To provide an overview of diagnostic and prognostic criteria for GEP-NETs.
• To focus on the impact of the latest WHO classification and ENETS/UICC TNM staging systems.
• To highlight how these criteria influence clinical and therapeutic approaches for GEP-NETs.

Main Methods:

• Review of recently published WHO classification for GEP-NETs.
• Analysis of ENETS and UICC TNM staging systems for GEP-NETs.
• Discussion of the clinical and therapeutic implications of these criteria.

Main Results:

• The study outlines updated diagnostic and prognostic criteria for GEP-NETs.
• It details the ENETS and UICC TNM staging systems and their components.
• The impact of these classifications on treatment planning and follow-up is emphasized.

Conclusions:

• Standardized prognostic stratification tools are essential for managing GEP-NETs.
• The WHO classification and TNM staging systems provide a framework for tailored patient management.
• Effective target therapies and updated staging systems offer new therapeutic horizons for GEP-NETs.